Öffentlicher Auftraggeber in Freiburg
Universitätsklinikum Freiburg
In 26 Bekanntmachungen genannt, seit 1. Januar 2009, aber in keiner als Auftragnehmer eines Zuschlags.
Fördermittel
Kohesio und Finanztransparenzsystem der EU, so gezählt.
167 Förderungen, zusammen 60,9 Mio. €.
| Quelle | Balken | Betrag | Förderungen |
|---|---|---|---|
| EU-Haushalt (Finanztransparenzsystem) | 60,9 Mio. €167 | 167 |
| Jahr | Programm | Projekt | Betrag und Beleg |
|---|---|---|---|
| 2025 | EU Budget - European CommissionERCEA - European Research Council101170596 - MAGIX - MUCOCILIARY ADAPTATIONS AND GUT MICROBIOME ESTABLISHMENT IN XENOPUS | 101170596 - MAGIX - MUCOCILIARY ADAPTATIONS AND GUT MICROBIOME ESTABLISHMENT IN XENOPUS | 498.980 €Beleg: Förderung 2025/4500081191.00010, Empfänger 38146Mittelbindung |
| 2025 | EU Budget - European CommissionERCEA - European Research Council101170596 - MAGIX - MUCOCILIARY ADAPTATIONS AND GUT MICROBIOME ESTABLISHMENT IN XENOPUS | 101170596 - MAGIX - MUCOCILIARY ADAPTATIONS AND GUT MICROBIOME ESTABLISHMENT IN XENOPUS | 1.496.941 €Beleg: Förderung 2025/4500081191.00020, Empfänger 37866Mittelbindung |
| 2025 | EU Budget - European CommissionREA - European Research Executive AgencyTRANSLATIONAL RESEARCH AND TRAINING ON ATRIAL CARDIOMYOPATHY AS A KEY TO BETTER ATRIAL FIBRILLATION MANAGEMENT | TRANSLATIONAL RESEARCH AND TRAINING ON ATRIAL CARDIOMYOPATHY AS A KEY TO BETTER ATRIAL FIBRILLATION MANAGEMENT | 232.218 €Beleg: Förderung 2025/4500111927.00010, Empfänger 76002Mittelbindung |
| 2025 | EU Budget - European CommissionREA - European Research Executive AgencyTRANSLATIONAL RESEARCH AND TRAINING ON ATRIAL CARDIOMYOPATHY AS A KEY TO BETTER ATRIAL FIBRILLATION MANAGEMENT | TRANSLATIONAL RESEARCH AND TRAINING ON ATRIAL CARDIOMYOPATHY AS A KEY TO BETTER ATRIAL FIBRILLATION MANAGEMENT | 58.054 €Beleg: Förderung 2025/4500111927.00020, Empfänger 76013Mittelbindung |
| 2025 | EU Budget - European CommissionREA - European Research Executive AgencyNETWORKED DISTRIBUTED NEURAL INTERFACES FOR INTERFERENCE-BASED BRAIN STIMULATION | NETWORKED DISTRIBUTED NEURAL INTERFACES FOR INTERFERENCE-BASED BRAIN STIMULATION | 232.218 €Beleg: Förderung 2025/4500112146.00010, Empfänger 58101Mittelbindung |
| 2025 | EU Budget - European CommissionREA - European Research Executive AgencyNETWORKED DISTRIBUTED NEURAL INTERFACES FOR INTERFERENCE-BASED BRAIN STIMULATION | NETWORKED DISTRIBUTED NEURAL INTERFACES FOR INTERFERENCE-BASED BRAIN STIMULATION | 58.055 €Beleg: Förderung 2025/4500112146.00020, Empfänger 58110Mittelbindung |
| 2025 | EU Budget - European CommissionREA - European Research Executive AgencyTARGETING EXTRACELLULAR MATRIX REMODELLING IN CUTANEOUS WOUNDS TO PROMOTE BETTER HEALING | TARGETING EXTRACELLULAR MATRIX REMODELLING IN CUTANEOUS WOUNDS TO PROMOTE BETTER HEALING | 116.109 €Beleg: Förderung 2025/4500114469.00010, Empfänger 54840Mittelbindung |
| 2025 | EU Budget - European CommissionREA - European Research Executive AgencyTARGETING EXTRACELLULAR MATRIX REMODELLING IN CUTANEOUS WOUNDS TO PROMOTE BETTER HEALING | TARGETING EXTRACELLULAR MATRIX REMODELLING IN CUTANEOUS WOUNDS TO PROMOTE BETTER HEALING | 464.436 €Beleg: Förderung 2025/4500114469.00020, Empfänger 54829Mittelbindung |
| 2024 | EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101057438 - GENETIGA - GENE-EDITED T CELLS COMBATING IGA NEPHROPATHY. A BLUEPRINT APPROACH FOR SAFE & EFFICIENT GENOME EDITING OF T CELLS TO SUSTAINABLY COMBAT SEVERAL IMMUNE DISEASES AND CANCERS RELATED TO B-CELL PATHOLOGY | 101057438 - GENETIGA - GENE-EDITED T CELLS COMBATING IGA NEPHROPATHY. A BLUEPRINT APPROACH FOR SAFE & EFFICIENT GENOME EDITING OF T CELLS TO SUSTAINABLY COMBAT SEVERAL IMMUNE DISEASES AND CANCERS RELATED TO B-CELL PATHOLOGY | 102.769 €Beleg: Förderung 2024/JAG.1005014.6, Empfänger 99472Mittelbindung |
| 2024 | EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101057659 - EDITSCD - ASSESSING EFFICACY AND SAFETY OF GENOME EDITING APPROACHES FOR SICKLE CELL DISEASE | 101057659 - EDITSCD - ASSESSING EFFICACY AND SAFETY OF GENOME EDITING APPROACHES FOR SICKLE CELL DISEASE | 108.068 €Beleg: Förderung 2024/JAG.1006306.8, Empfänger 90671Mittelbindung |
| 2024 | EU Budget - European CommissionEISMEA - Eur.Innov.Coun. & SMEs EA101099719 - THOR - BUILDING VASCULAR NETWORKS AND BLOOD-BRAIN-BARRIERS THROUGH A BIOMIMETIC MANUFACTURING TECHNOLOGY FOR THE FABRICATION OF HUMAN TISSUES AND ORGANS | 101099719 - THOR - BUILDING VASCULAR NETWORKS AND BLOOD-BRAIN-BARRIERS THROUGH A BIOMIMETIC MANUFACTURING TECHNOLOGY FOR THE FABRICATION OF HUMAN TISSUES AND ORGANS | 108.926 €Beleg: Förderung 2024/JAG.1153209.4, Empfänger 71749Mittelbindung |
| 2024 | EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101156434 - EURO-NMD 23-27 - EUROPEAN REFERENCE NETWORK FOR RARE NEUROMUSCULAR DISEASES 23-27 | 101156434 - EURO-NMD 23-27 - EUROPEAN REFERENCE NETWORK FOR RARE NEUROMUSCULAR DISEASES 23-27 | 620.115 €Beleg: Förderung 2024/JAG.1460387.1, Empfänger 91033Mittelbindung |
| 2024 | EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101156595 - ERDERA - EUROPEAN RARE DISEASES RESEARCH ALLIANCE | 101156595 - ERDERA - EUROPEAN RARE DISEASES RESEARCH ALLIANCE | 200.490 €Beleg: Förderung 2024/JAG.1570674.1, Empfänger 89284Mittelbindung |
| 2024 | EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101155873 - SP-EU - SOCIAL PRESCRIBING TO PROMOTE AND IMPROVE ACCESS TO HEALTH AND CARE SERVICES FOR PEOPLE IN VULNERABLE SITUATIONS IN EUROPE | 101155873 - SP-EU - SOCIAL PRESCRIBING TO PROMOTE AND IMPROVE ACCESS TO HEALTH AND CARE SERVICES FOR PEOPLE IN VULNERABLE SITUATIONS IN EUROPE | 29.373 €Beleg: Förderung 2024/JAG.1653316.1, Empfänger 97670Mittelbindung |
| 2024 | EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101155873 - SP-EU - SOCIAL PRESCRIBING TO PROMOTE AND IMPROVE ACCESS TO HEALTH AND CARE SERVICES FOR PEOPLE IN VULNERABLE SITUATIONS IN EUROPE | 101155873 - SP-EU - SOCIAL PRESCRIBING TO PROMOTE AND IMPROVE ACCESS TO HEALTH AND CARE SERVICES FOR PEOPLE IN VULNERABLE SITUATIONS IN EUROPE | 337.793 €Beleg: Förderung 2024/JAG.1653316.2, Empfänger 97653Mittelbindung |
| 2023 | EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101101261 - TRANSITION - DIGITAL TRANSITION AND DIGITAL RESILIENCE IN ONCOLOGY | 101101261 - TRANSITION - DIGITAL TRANSITION AND DIGITAL RESILIENCE IN ONCOLOGY | 68.480 €Beleg: Förderung 2023/JAG.1180374.1, Empfänger 60046Mittelbindung |
| 2023 | EU Budget - European CommissionREA - European Research Executive Agency101106452 - STIC-GBM - SPATIO-TEMPORAL DYNAMICS OF IMMUNE CIRCUITRY IN GLIOBLASTOMA: FROM SINGLE CELLS TO COMPREHENSIVE MODELS OF TUMOR NICHES | 101106452 - STIC-GBM - SPATIO-TEMPORAL DYNAMICS OF IMMUNE CIRCUITRY IN GLIOBLASTOMA: FROM SINGLE CELLS TO COMPREHENSIVE MODELS OF TUMOR NICHES | 184.698 €Beleg: Förderung 2023/JAG.1199953.1, Empfänger 27535Mittelbindung |
| 2023 | EU Budget - European CommissionEISMEA - Eur.Innov.Coun. & SMEs EA101112739 - ROBIOPSY - AI AND ROBOTICS FOR PROSTATE BIOPSY | 101112739 - ROBIOPSY - AI AND ROBOTICS FOR PROSTATE BIOPSY | 187.765 €Beleg: Förderung 2023/JAG.1215247.1, Empfänger 116938Mittelbindung |
| 2023 | EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101080997 - RECON4IMD - RECONSTRUCTION AND COMPUTATIONAL MODELLING FOR INHERITED METABOLIC DISEASES | 101080997 - RECON4IMD - RECONSTRUCTION AND COMPUTATIONAL MODELLING FOR INHERITED METABOLIC DISEASES | 6.665 €Beleg: Förderung 2023/JAG.1218562.1, Empfänger 108956Mittelbindung |
| 2023 | EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101080997 - RECON4IMD - RECONSTRUCTION AND COMPUTATIONAL MODELLING FOR INHERITED METABOLIC DISEASES | 101080997 - RECON4IMD - RECONSTRUCTION AND COMPUTATIONAL MODELLING FOR INHERITED METABOLIC DISEASES | 3.333 €Beleg: Förderung 2023/JAG.1218562.2, Empfänger 108974Mittelbindung |
| 2023 | EU Budget - European CommissionX - ERC - European Research Council Executive Agency101094168 - ALLOCURE - DECIPHERING CELLULAR SIGNALLING TO CURE GRAFT-VERSUS-HOST DISEASE (GVHD) AND LEUKEMIA RELAPSE | 101094168 - ALLOCURE - DECIPHERING CELLULAR SIGNALLING TO CURE GRAFT-VERSUS-HOST DISEASE (GVHD) AND LEUKEMIA RELAPSE | 2.498.943 €Beleg: Förderung 2023/JAG.1258343.1, Empfänger 26737Mittelbindung |
| 2023 | EU Budget - European CommissionREA - European Research Executive Agency101119951 - ECLECTIC - ELECTROCHEMILUMINESCENCE DOCTORAL NETWORK FOR EARLY SEPSIS DIAGNOSIS | 101119951 - ECLECTIC - ELECTROCHEMILUMINESCENCE DOCTORAL NETWORK FOR EARLY SEPSIS DIAGNOSIS | 243.865 €Beleg: Förderung 2023/JAG.1275355.1, Empfänger 115255Mittelbindung |
| 2023 | EU Budget - European CommissionREA - European Research Executive Agency101119951 - ECLECTIC - ELECTROCHEMILUMINESCENCE DOCTORAL NETWORK FOR EARLY SEPSIS DIAGNOSIS | 101119951 - ECLECTIC - ELECTROCHEMILUMINESCENCE DOCTORAL NETWORK FOR EARLY SEPSIS DIAGNOSIS | 16.675 €Beleg: Förderung 2023/JAG.1275355.2, Empfänger 115265Mittelbindung |
| 2023 | EU Budget - European CommissionREA - European Research Executive Agency101119927 - IMMERGE - STORMING IMMUNE MONOGENIC CONDITIONS THROUGH MULTIOMIC AND GENE EDITING APPROACHES | 101119927 - IMMERGE - STORMING IMMUNE MONOGENIC CONDITIONS THROUGH MULTIOMIC AND GENE EDITING APPROACHES | 33.349 €Beleg: Förderung 2023/JAG.1280945.1, Empfänger 70298Mittelbindung |
| 2023 | EU Budget - European CommissionREA - European Research Executive Agency101119927 - IMMERGE - STORMING IMMUNE MONOGENIC CONDITIONS THROUGH MULTIOMIC AND GENE EDITING APPROACHES | 101119927 - IMMERGE - STORMING IMMUNE MONOGENIC CONDITIONS THROUGH MULTIOMIC AND GENE EDITING APPROACHES | 487.729 €Beleg: Förderung 2023/JAG.1280945.2, Empfänger 70290Mittelbindung |
Angaben aus den Bekanntmachungen
26 Nennungen seit 1. Januar 2009, zuletzt am 22. Oktober 2026, dieser Stelle zugeordnet. Wie wir zuordnen
- Anschrift
- Agnesenstraße 6-8, 79106 Freiburg
- USt-IdNr.
- DE811506626
- Vergabestellen
- Universitätsklinikum Freiburg
- UNIVERSITATSKLINIKUM FREIBURG